188 results on '"Bouma, Gerd"'
Search Results
2. Cerebellar presence of immune cells in patients with neuro-coeliac disease
3. Activated CD27+PD-1+ CD8 T Cells and CD4 T Regulatories Dominate the Tumor Microenvironment in Refractory Celiac Disease Type II
4. Enduring Clinical Remission in Refractory Celiac Disease Type II with Tofacitinib: An Open-Label Clinical Study
5. Standardizing Randomized Controlled Trials in Celiac Disease: An International Multidisciplinary Appropriateness Study
6. Potential of Mesalazine Therapeutic Drug Monitoring by Measuring Fecal Excretion in Patients With Ulcerative Colitis
7. Superior Effectiveness of Tofacitinib Compared to Vedolizumab in Anti-TNF-experienced Ulcerative Colitis Patients: A Nationwide Dutch Registry Study
8. Celiac disease: New therapies on the horizon
9. Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial
10. Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study
11. Methotrexate accumulation in target intestinal mucosa and white blood cells differs from non‐target red blood cells of patients with Crohn's disease.
12. Single-Cell Analysis of Refractory Celiac Disease Demonstrates Inter- and Intra-Patient Aberrant Cell Heterogeneity
13. Drug withdrawal in patients with autoimmune hepatitis in long-term histological remission: A prospective observational study
14. Rapid Response to Treatment of Autoimmune Hepatitis Associated With Remission at 6 and 12 Months
15. Safety and efficacy of AMG 714 in patients with type 2 refractory coeliac disease: a phase 2a, randomised, double-blind, placebo-controlled, parallel-group study
16. Predniso(lo)ne Dosage and Chance of Remission in Patients With Autoimmune Hepatitis
17. Association Between Black Race and Presentation and Liver-Related Outcomes of Patients With Autoimmune Hepatitis
18. Increased Mortality Among Patients With vs Without Cirrhosis and Autoimmune Hepatitis
19. Clinical Course of Nodular Regenerative Hyperplasia in Thiopurine Treated Inflammatory Bowel Disease Patients
20. Efficacy and Safety of Budesonide, vs Mesalazine or Placebo, as Induction Therapy for Lymphocytic Colitis
21. Lack of complete biochemical response in autoimmune hepatitis leads to adverse outcome: First report of the IAIHG retrospective registry.
22. Transient elastography to assess liver stiffness in patients with inflammatory bowel disease
23. CD4 T-cell cytokines synergize to induce proliferation of malignant and nonmalignant innate intraepithelial lymphocytes
24. Therapeutic drug monitoring of methotrexate in patients with Crohn's disease.
25. Intestinal epithelial cell transported TLR2 ligand stimulates Ly6C+ monocyte differentiation in a G-CSF dependent manner
26. Methotrexate and Thioguanine Rescue Therapy for Conventional Thiopurine Failing Ulcerative Colitis Patients: A Multi-center Database Study on Tolerability and Effectiveness
27. Role of age in presentation, response to therapy and outcome of autoimmune hepatitis
28. Salivary Function and Oral Health Problems in Crohn’s Disease Patients
29. Sex-Related Differences in Patients With Inflammatory Bowel Disease: Results of 2 Prospective Cohort Studies
30. Optimizing Thiopurine Therapy in Inflammatory Bowel Disease Among 2 Real-life Intercept Cohorts: Effect of Allopurinol Comedication?
31. Sustained Clinical Benefit and Tolerability of Methotrexate Monotherapy After Thiopurine Therapy in Patients With Crohn's Disease
32. Trichuris suis-induced modulation of human dendritic cell function is glycan-mediated
33. High myeloid‐derived suppressor cell frequencies in the duodenum are associated with enteropathy associated T‐cell lymphoma and its precursor lesions
34. Nodular Regenerative Hyperplasia of the Liver in Patients with IBD Treated with Allopurinol–Thiopurine Combination Therapy
35. A meta‐analysis of methotrexate polyglutamates in relation to efficacy and toxicity of methotrexate in inflammatory arthritis, colitis and dermatitis.
36. Electronic Nose Sensor Drift Affects Diagnostic Reliability and Accuracy of Disease-Specific Algorithms.
37. INSPECT: A Retrospective Study to Evaluate Long-term Effectiveness and Safety of Darvadstrocel in Patients With Perianal Fistulizing Crohn's Disease Treated in the ADMIRE-CD Trial.
38. Immunoglobulin A: FcαRI Interactions Induce Neutrophil Migration Through Release of Leukotriene B4
39. Mechanisms and management of refractory coeliac disease
40. Treatment response in enteropathy associated T-cell lymphoma; survival in a large multicenter cohort
41. Assessment of the histopathological key features in autoimmune hepatitis
42. Fcα Receptor-1-Activated Monocytes Promote B Lymphocyte Migration and IgA Isotype Switching.
43. Non-Responsive and Refractory Coeliac Disease: Experience from the NHS England National Centre.
44. Cytotoxic T Lymphocyte Antigen–4 +49A/G polymorphism does not affect susceptibility to autoimmune hepatitis
45. 789 CALY-002, AN ANTI-IL-15 ANTIBODY, PREVENTS GLUTEN CHALLENGEINDUCED MUCOSAL DAMAGE AND INFLAMMATION: RESULTS FROM A PHASE 1A/B STUDY.
46. Nod2 improves barrier function of intestinal epithelial cells via enhancement of TLR responses
47. Video capsule endoscopy for previous overt obscure gastrointestinal bleeding in patients using anti-thrombotic drugs
48. Soluble helminth products suppress clinical signs in murine experimental autoimmune encephalomyelitis and differentially modulate human dendritic cell activation
49. Origin and immunophenotype of aberrant IEL in RCDII patients
50. Outcomes of push and pull percutaneous endoscopic gastrostomy placements in 854 patients: A single‐center study.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.